Quantitation of host cell proteins in biopharmaceuticals from chinese hamster ovarian and vero cell lines using capillary electrophoresis western blots-Reference-Cited by-同舟云学术

Quantitation of host cell proteins in biopharmaceuticals from chinese hamster ovarian and vero cell lines using capillary electrophoresis western blots

Published:2023-09 Issue: Volume:233 Page:115420
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Pearson Cara,Wang Yi,Alkurdi Eman,Zhang Young,Yin Kuo,Rustandi Richard R.,Loughney John W.

Funder

Merck

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference37 articles.

1. Host cell proteins in biotechnology-derived products: a risk assessment framework;De Zafra;Biotechnol. Bioeng.,2015

2. Specific immune response to phospholipase-B-like protein, a host cell impurity in lebrikizumab clinical material;Fischer;AAPS J.,2017

3. Degradation of an Fc-fusion recombinant protein by host cell proteases: identification of a CHO capthepsin D protease;Robert;Biotechnol. Bioeng.,2009

4. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity;Gao;Biotechnol. Bioeng.,2010

5. Polysorbates 20 and 80 degradation by group XV lysosomal phospholipase A2 isomer in monoclonal antibody formulations;Hall;J. Pharm. Sci.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Application of Automated Sandwich ELISA for Quantitating Residual dsRNA in mRNA Vaccines;Vaccines;2024-08-08

2. Explore the action mechanism of Danggui Buxue decoction on chronic heart failure in rats by proteomics and untargeted metabolomics;Journal of Traditional and Complementary Medicine;2024-08

3. Detection of residual T7 RNA polymerase used in mRNA in vitro transcription by Simple Western;ELECTROPHORESIS;2024-06-20

4. Expression system and purification process for the vaccine production;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024